Literature DB >> 17478001

The role of GSK3 in glucose homeostasis and the development of insulin resistance.

Jongsoon Lee1, Myung-Sunny Kim.   

Abstract

GSK3 has been implicated in the development of insulin resistance, primarily based on its role in regulation of glycogen synthesis. However, GSK3 is involved in many other important signaling cascades which may regulate glucose homeostasis and the development of insulin resistance. In addition, GSK3 is composed of two isoforms, GSK3alpha and beta, which do not completely share their physiological roles, and this raises a possibility that GSK3alpha and beta may function differently in glucose homeostasis. In this review, we will give an overview to examine potential mechanisms for the roles of GSK3 in the development of insulin resistance.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17478001     DOI: 10.1016/j.diabres.2007.01.033

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  69 in total

1.  C-terminal region of GADD34 regulates eIF2α dephosphorylation and cell proliferation in CHO-K1 cells.

Authors:  Ryo Otsuka; Nagakatsu Harada; Shouhei Aoki; Kanna Shirai; Kazuchika Nishitsuji; Ayane Nozaki; Adzumi Hatakeyama; Masayuki Shono; Noriko Mizusawa; Katsuhiko Yoshimoto; Yutaka Nakaya; Hiroshi Kitahata; Hiroshi Sakaue
Journal:  Cell Stress Chaperones       Date:  2015-08-30       Impact factor: 3.667

2.  Glycogen synthase kinase (GSK)-3 promotes p70 ribosomal protein S6 kinase (p70S6K) activity and cell proliferation.

Authors:  Sejeong Shin; Laura Wolgamott; Yonghao Yu; John Blenis; Sang-Oh Yoon
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-07       Impact factor: 11.205

3.  The AMPK β2 subunit is required for energy homeostasis during metabolic stress.

Authors:  Biplab Dasgupta; Jeong Sun Ju; Yo Sasaki; Xiaona Liu; Su-Ryun Jung; Kazuhiko Higashida; Diana Lindquist; Jeffrey Milbrandt
Journal:  Mol Cell Biol       Date:  2012-05-14       Impact factor: 4.272

4.  Measures of striatal insulin resistance in a 6-hydroxydopamine model of Parkinson's disease.

Authors:  J K Morris; H Zhang; A A Gupte; G L Bomhoff; J A Stanford; P C Geiger
Journal:  Brain Res       Date:  2008-09-11       Impact factor: 3.252

5.  Impacts of rat hindlimb Fndc5/irisin overexpression on muscle and adipose tissue metabolism.

Authors:  W Farrash; M Brook; H Crossland; B E Phillips; J Cegielski; D J Wilkinson; D Constantin-Teodosiu; P L Greenhaff; K Smith; M Cleasby; P J Atherton
Journal:  Am J Physiol Endocrinol Metab       Date:  2020-05-05       Impact factor: 4.310

Review 6.  Insulin resistance in clinical and experimental alcoholic liver disease.

Authors:  Rotonya M Carr; Jason Correnti
Journal:  Ann N Y Acad Sci       Date:  2015-05-21       Impact factor: 5.691

Review 7.  Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications.

Authors:  Evanthia Diamanti-Kandarakis; Andrea Dunaif
Journal:  Endocr Rev       Date:  2012-10-12       Impact factor: 19.871

8.  Glycogen synthase kinase 3 β activity is required for hBora/Aurora A-mediated mitotic entry.

Authors:  Yu-Cheng Lee; Po-Chi Liao; Yih-Cherng Liou; Michael Hsiao; Chi-Ying Huang; Pei-Jung Lu
Journal:  Cell Cycle       Date:  2013-02-26       Impact factor: 4.534

Review 9.  Molecular mechanisms involved in NAFLD progression.

Authors:  Mariano Malaguarnera; Michelino Di Rosa; Ferdinando Nicoletti; Lucia Malaguarnera
Journal:  J Mol Med (Berl)       Date:  2009-04-08       Impact factor: 4.599

10.  Effects of insulin on the metabolic control of hepatic gluconeogenesis in vivo.

Authors:  Dale S Edgerton; Christopher J Ramnanan; Carrie A Grueter; Kathryn M S Johnson; Margaret Lautz; Doss W Neal; Phillip E Williams; Alan D Cherrington
Journal:  Diabetes       Date:  2009-09-15       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.